bioAffinity Technologies, Inc. (BIAF) — Financial statements
Income statement, balance sheet, and cash flow for bioAffinity Technologies, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 6↓34.2% | 9↑269.7% | 3↑52617.1% | 0.00 | 0.00 | |
| Cost of Revenue | 5↓20.9% | 6↑243.7% | 2↑372705.1% | 0.00↓90.3% | 0.00 | |
| Gross Profit | 1↓57.7% | 3↑326.8% | 0.79↑18156.8% | 0.00↑190.0% | -0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 2↑17.2% | 2↑3.4% | 2↑13.2% | 2↑14.9% | 1 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 10↓0.3% | 10↑46.4% | 7↑173.7% | 2↑183.2% | 0.88 | |
| Other Expenses | 0.00↓100.0% | 0.61↑142.8% | 0.25↑2351.3% | 0.01 | 0.00 | |
| Operating Expenses | 12↓2.7% | 12↑40.7% | 9↑118.3% | 4↑82.4% | 2 | |
| Total Costs & Expenses | 17↓8.6% | 18↑74.3% | 11↑161.6% | 4↑82.0% | 2 | |
| Operating Results | ||||||
| Operating Income | -11↓18.1% | -9↓12.3% | -8↓98.8% | -4↓81.8% | -2 | |
| Depreciation & Amortization | 0.50↓16.6% | 0.61↑142.7% | 0.25↑2351.3% | 0.01↑111.4% | 0.00 | |
| EBITDA | -10↓20.9% | -8↓9.2% | -8↓36.0% | -6↓5.5% | -5 | |
| EBIT | -11↓18.3% | -9↓13.4% | -8↓40.2% | -6↓5.6% | -5 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.02↑72.0% | -0.07↓188.1% | 0.09↑103.4% | -2↓148.4% | -1 | |
| Interest Income | 0.02↑32.8% | 0.02↓85.6% | 0.12↑161.5% | 0.05↑10916.0% | 0.00 | |
| Interest Expense | 0.04↓52.0% | 0.09↑149.1% | 0.04↓98.5% | 3↑152.8% | 1 | |
| Non-Operating Income | 0.00↑100.0% | -0.02↑81.2% | -0.09↓105.9% | 2↓48.4% | 3 | |
| Other Income / Expenses | -4↓5597.7% | -0.08↓231.7% | 0.06↑101.4% | -4↓0.6% | -4 | |
| Income Before Tax | -15↓64.7% | -9↓14.1% | -8↑2.9% | -8↓28.9% | -6 | |
| Income Tax Expense | 0.04↑278.0% | 0.01↓44.5% | 0.02↑753.7% | 0.00↑26.1% | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -15↓64.9% | -9↓13.9% | -8↑2.7% | -8↓28.9% | -6 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -15↓64.9% | -9↓13.9% | -8↑2.7% | -8↓28.9% | -6 | |
| Bottom-Line Net Income | -15↓64.9% | -9↓13.9% | -8↑2.7% | -8↓28.9% | -6 | |
| EPS (Basic) | -8.66↑61.5% | -22.50↑17.6% | -27.30↑49.7% | -54.30↑23.4% | -70.86 | |
| EPS (Diluted) | -8.66↑61.5% | -22.50↑17.6% | -27.30↑49.7% | -54.30↑21.9% | -69.57 | |
| Weighted Average Shares | 2↑325.7% | 0.40↑38.7% | 0.29↑94.4% | 0.15↑68.0% | 0.09 | |
| Weighted Average Diluted Shares | 2↑325.7% | 0.40↑38.7% | 0.29↑94.4% | 0.15↑64.9% | 0.09 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.